%0 Journal Article %T Strategies for first-line immunotherapy in squamous cell lung cancer: are combinations a game changer? %A Karachaliou, Niki %A Fernandez-Bruno, Manuel %A Rosell, Rafael %J Translational Lung Cancer Research %D 2018 %B 2018 %9 %! Strategies for first-line immunotherapy in squamous cell lung cancer: are combinations a game changer? %K %X The initial treatment for metastatic squamous cell non-small cell lung cancer (NSCLC) consists of platinum-based combination chemotherapy. The most commonly used regimens are carboplatin and paclitaxel, carboplatin and protein-bound paclitaxel (nab-paclitaxel), and cisplatin and gemcitabine. %U https://tlcr.amegroups.org/article/view/22760 %P S198-S201 %@ 2226-4477